中国医疗-中国临床前 CRO 专家电话会要点-China Healthcare _China preclinical CRO expert call takeaways_ Chen

ab 8 December 2025 Global Research China Healthcare China preclinical CRO expert call takeaways Notable volume & price recovery in Q425; more potential upside in 2026 On 5 Dec, we invited a senior executive from a domestic medium-sized private preclinical CRO firm to share his views. He noted a clear recovery in China's preclinical CRO industry in Q425—the trend turned stronger in the second half of Nov. For projects involving NHP, order inflow in Q425 is up c30% QoQ in volume terms, and up 10-20% sequentia ...